In her complaint against L’Oreal and other marketers of hair-smoothing products, plaintiff Jenny Mitchell, who was diagnosed with uterine cancer in August 2018, cites an NIH study published in October as “the first epidemiologic evidence of association between use of straightening products and uterine cancer.” She claims the defendants engaged in negligent or fraudulent practices in their marketing and sale of hair-straightening products that they knew posed dangers to users.
Hair-straightening products from L’Oreal USA, Inc. and co-defendants contain phthalates and other endocrine-disrupting substances that consumers should have been warned about due to cancer risks, according to plaintiff Jenny Mitchell, who was diagnosed with uterine cancer in August 2018.
In a complaint filed on 21 October in Illinois federal court, Mitchell alleges that L’Oreal USA, Strength of Nature Global, LLC, Soft Sheen Caron Inc., Dabur USA, Inc
Firms in the US facing tariff costs should identify US-based, non-tariff sources and lobby local government officials and DC when foreign-sourced ingredients cannot be substituted in the US.
By guiding regulators through case studies and mock dossier examples of how to utilize new approach methodologies, the International Collaboration on Cosmetics Safety hopes to counter hesitations in replacing animal tests.
The US Food and Drug Administration has released a roadmap to adopt new approach methodologies in lieu of animal testing for monoclonal antibody therapies and other drugs, which may include OTC drugs though the proposal does not specifically include cosmetics.
